Proteomics Market worth $65.78 billion by 2030
The report "Proteomics Market by Product (Spectroscopy, Chromatography, Electrophoresis, X-Ray Crystallography), Reagent, Service (Core Proteomics, Bioinformatics), Application (Diagnostic, Drug Discovery), End User (Hospital, Biopharma) - Global Forecast to 2030” is projected to grow from USD 36.32 billion in 2025 and to reach USD 65.78 billion by 2030, at a Compound Annual Growth Rate (CAGR) of 12.6% during the forecast period.
Browse 1000 market data Tables and 55 Figures spread through 800 Pages and in-depth TOC on "Proteomics Market by Product (Spectroscopy, Chromatography, Electrophoresis, X-Ray Crystallography), Reagent, Service (Core Proteomics, Bioinformatics), Application (Diagnostic, Drug Discovery), End User (Hospital, Biopharma) - Global Forecast to 2030”
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/proteomics-market-731.html
The growing adoption of mass spectrometry-based research, biomarker discovery, and precision medicine initiatives is supporting the proteomics market. Proteomics is used increasingly in pharma, biotech, and clinical research labs. Thus, the need for accurate protein identification, reliable quantification, and high-quality sample preparation is increasing.
The spectroscopy segment held the largest market share, by technique, in 2024.
Spectroscopy accounted for the largest share of the proteomics market in 2024. The dominance of spectroscopy in the global proteomics market is driven by its strong accuracy and sensitivity for protein detection and quantification. It enables reliable profiling even in complex samples, which makes it a preferred choice across high-throughput research workflows. Spectroscopy-based systems also support deeper biological interpretation through robust protein identification and quantification methods. The spectroscopy sub-market is segmented into mass spectroscopy, NMR spectroscopy, and CD spectroscopy.
In 2024, the clinical diagnostics segment is expected to be the fastest-growing application.
By application, the market is divided into clinical diagnostics, drug discovery and development, and other applications. Of these, clinical diagnostics held the largest share in the market in 2024. This is due to the rising use of proteomics in precision medicine and personalized healthcare across major global markets. Providers are focused beyond genes and adding protein-level signatures to improve clinical decisions. Demand is growing for proteomics tools that can identify and validate biomarkers for diseases with strong reproducibility.
North America accounted for the largest regional share in the global proteomics market in 2024.
North America represents the largest regional market for proteomics. The large share is supported by the strong presence of biotechnology and pharmaceutical companies, along with sustained R&D spending across discovery and translational programs. The region also benefits from a dense concentration of leading mass spectrometry vendors, proteomics reagent suppliers, and specialist service providers, which keeps adoption high and workflows well supported.
Key players in the proteomics market include Thermo Fisher Scientific Inc. (US), Danaher Corporation (US), Agilent Technologies (US), Bio-Rad Laboratories (US), Revvity (US), Illumina Inc. (US), and Promega Corporation (US), among others.
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the Proteomics Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
